2 Firms Lead Assertio Buy Of Spectrum Pharma For $248M
Pharma companies Assertio Holdings Inc. and Spectrum Pharmaceuticals Inc. announced on Tuesday that they had reached an agreement for the former to buy the latter, in a deal worth roughly $248 million...To view the full article, register now.
Already a subscriber? Click here to view full article